Abstract
A 2006 publication entitled ‘Catalytic Antioxidants to Treat Amyotrophic Lateral Sclerosis’ summarized the therapeutic effects of metalloporphyrins (MPs) and metallotexaphyrins (MTs) in the G93A superoxide dismutase (SOD1) mouse model of amyotrophic lateral sclerosis (ALS) [1].
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
